Karen Mulder

1.6k total citations
47 papers, 1.1k citations indexed

About

Karen Mulder is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Karen Mulder has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 30 papers in Pulmonary and Respiratory Medicine and 23 papers in Surgery. Recurrent topics in Karen Mulder's work include Gastric Cancer Management and Outcomes (25 papers), Colorectal Cancer Treatments and Studies (23 papers) and Colorectal Cancer Surgical Treatments (13 papers). Karen Mulder is often cited by papers focused on Gastric Cancer Management and Outcomes (25 papers), Colorectal Cancer Treatments and Studies (23 papers) and Colorectal Cancer Surgical Treatments (13 papers). Karen Mulder collaborates with scholars based in Canada, United States and South Korea. Karen Mulder's co-authors include Michael B. Sawyer, Andrew Scarfe, Jennifer L. Spratlin, Marina Mourtzakis, Linda J. McCargar, Vickie E. Baracos, Charles Butts, Tony Reiman, Carla M. Prado and Sunita Ghosh and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Karen Mulder

46 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karen Mulder Canada	15	508	393	292	282	175	47	1.1k
Zengqing Guo China	17	397 0.8×	419 1.1×	212 0.7×	187 0.7×	217 1.2×	74	1.0k
Antonia Strippoli Italy	17	532 1.0×	236 0.6×	438 1.5×	328 1.2×	78 0.4×	66	1.1k
Hei Cheul Jeung South Korea	15	432 0.9×	226 0.6×	327 1.1×	433 1.5×	58 0.3×	32	941
Rohan Gupta United States	15	503 1.0×	173 0.4×	312 1.1×	311 1.1×	107 0.6×	50	932
Mayuko Ohuchi Japan	13	428 0.8×	431 1.1×	191 0.7×	313 1.1×	218 1.2×	31	878
R. de las Peñas Spain	15	438 0.9×	263 0.7×	460 1.6×	163 0.6×	106 0.6×	63	1.1k
Tomoyuki Matsunaga Japan	23	757 1.5×	230 0.6×	644 2.2×	638 2.3×	101 0.6×	137	1.7k
Keisuke Kosumi Japan	24	717 1.4×	363 0.9×	468 1.6×	707 2.5×	130 0.7×	92	1.7k
Kosei Takagi Japan	15	527 1.0×	276 0.7×	257 0.9×	545 1.9×	76 0.4×	110	1.0k
Kohei Wakatsuki Japan	19	546 1.1×	155 0.4×	526 1.8×	513 1.8×	33 0.2×	56	1.1k

Countries citing papers authored by Karen Mulder

Since Specialization

Citations

This map shows the geographic impact of Karen Mulder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Mulder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Mulder more than expected).

Fields of papers citing papers by Karen Mulder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Mulder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Mulder. The network helps show where Karen Mulder may publish in the future.

Co-authorship network of co-authors of Karen Mulder

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Mulder. A scholar is included among the top collaborators of Karen Mulder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Mulder. Karen Mulder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ko, Yoo-Joung, Petr Kavan, Haji Chalchal, et al.. (2025). Administration of FOLFIRINOX for Advanced Pancreatic Cancer: Physician Practice Patterns During Early Use. Current Oncology. 32(3). 128–128. 1 indexed citations

Gill, Sharlene, Shahid Ahmed, Scott Berry, et al.. (2023). Report from the 24th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Richmond, British Columbia, 28–29, October 2022. Current Oncology. 30(9). 7964–7983. 1 indexed citations

Breadner, Daniel, Jonathan M. Loree, Winson Y. Cheung, et al.. (2022). The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: a multicentered retrospective analysis. BMC Cancer. 22(1). 1119–1119. 4 indexed citations

Abraham, Aswin, Kurian Joseph, Jennifer L. Spratlin, et al.. (2022). Does Loosening the Inclusion Criteria of the CROSS Trial Impact Outcomes in the Curative-Intent Trimodality Treatment of Oesophageal and Gastroesophageal Cancer Patients?. Clinical Oncology. 34(9). e369–e376. 5 indexed citations

Abraham, Aswin, Nawaid Usmani, Heather Warkentin, et al.. (2021). Concomitant Use of Proton Pump Inhibitors With Capecitabine Based Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. American Journal of Clinical Oncology. 44(9). 487–494. 4 indexed citations

Abdel‐Rahman, Omar, Karen Mulder, & Jacob C. Easaw. (2021). Outcomes of Ramucirumab Plus Paclitaxel Among Patients With Previously Treated Metastatic Gastric/Lower Esophageal Cancer. American Journal of Clinical Oncology. 44(4). 158–161. 2 indexed citations

Abdel‐Rahman, Omar, Sheryl Koski, & Karen Mulder. (2020). Real-world patterns of chemotherapy administration and attrition among patients with metastatic colorectal cancer. International Journal of Colorectal Disease. 36(3). 493–499. 11 indexed citations

Loree, Jonathan M., Maryam Soleimani, Hagen F. Kennecke, et al.. (2018). Survival Impact of CAPOX Versus FOLFOX in the Adjuvant Treatment of Stage III Colon Cancer. Clinical Colorectal Cancer. 17(2). 156–163. 21 indexed citations

Kim, Christina, Shahid Ahmed, Shahid Ahmed, et al.. (2018). Report from the 19th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Winnipeg, Manitoba; 29–30 September 2017. Current Oncology. 25(4). 275–284. 1 indexed citations

10.

Mulder, Karen, Christine Brezden‐Masley, Michael M. Vickers, et al.. (2018). A multicentre, open-label phase II study of Irinotecan, capecitabine (Xeloda®), and Oxaliplatin (IXO) as first-line treatment in patients with metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma. Investigational New Drugs. 36(4). 674–682. 1 indexed citations

11.

Joseph, Kurian, Larissa J. Vos, Heather Warkentin, et al.. (2016). Patient reported quality of life after helical IMRT based concurrent chemoradiation of locally advanced anal cancer. Radiotherapy and Oncology. 120(2). 228–233. 33 indexed citations

12.

Maroun, Jean A., et al.. (2015). 2340 A registry of real-world clinical practice on the use of FOLFIRINOX (FFX) in advanced pancreatic cancer (aPC) patients in Canada. European Journal of Cancer. 51. S447–S448. 3 indexed citations

13.

Joseph, Kurian, Heather Warkentin, Dan Schiller, et al.. (2015). Prospective phase II study of tomotherapy based chemoradiation treatment for locally advanced anal cancer. Radiotherapy and Oncology. 117(2). 234–239. 15 indexed citations

14.

Yeung, Raymond S., Yarrow J. McConnell, Rintu Banerjee‬‬‬‬‬‬‬‬‬, et al.. (2014). One Compared with Two Cycles of Mitomycin C in Chemoradiotherapy for Anal Cancer: Analysis of Outcomes and Toxicity. Current Oncology. 21(3). 449–456. 22 indexed citations

15.

Loree, Jonathan M., Karen Mulder, Sunita Ghosh, & Jennifer L. Spratlin. (2014). Retrospective Comparison of CAPOX and FOLFOX Dose Intensity, Toxicity, and Clinical Outcomes in the Treatment of Metastatic Colon Cancer. Journal of Gastrointestinal Cancer. 45(2). 154–160. 7 indexed citations

16.

Kim, Christina, et al.. (2014). Efficacy and Safety of Single Agent or Combination Adjuvant Chemotherapy in Elderly Patients With Colon Cancer: A Canadian Cancer Institute Experience. Clinical Colorectal Cancer. 13(3). 199–206. 19 indexed citations

17.

Dechaphunkul, Arunee, Karen Mulder, Faraj El-Gehani, et al.. (2012). Clinicopathologic Characteristics and Survival Outcomes of Patients with Advanced Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma: A Single-Institution Experience. Current Oncology. 19(6). 302–307. 3 indexed citations

18.

Hiller, Julie Price, et al.. (2012). Impact of a Dedicated Cancer Center Surveillance Program on Guideline Adherence for Patients With Stage II and III Colorectal Cancer. Clinical Colorectal Cancer. 12(2). 103–112. 4 indexed citations

19.

Mulder, Karen, Andrew Scarfe, Neil Chua, & Jennifer L. Spratlin. (2011). The role of bevacizumab in colorectal cancer: understanding its benefits and limitations. Expert Opinion on Biological Therapy. 11(3). 405–413. 31 indexed citations

20.

Au, Heather‐Jane, Karen Mulder, & Anthony Fields. (2003). Systematic Review of Management of Colorectal Cancer in Elderly Patients. Clinical Colorectal Cancer. 3(3). 165–171. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact